# Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects

> **NCT05030857** · PHASE1 · COMPLETED · sponsor: **Lakefront Biotherapeutics NV** · enrollment: 19 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** GLPG4716
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT05030857
- **Lead sponsor:** Lakefront Biotherapeutics NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-08
- **Primary completion:** 2021-11-13
- **Final completion:** 2021-11-13
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2021-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05030857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05030857, "Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05030857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*